Friday, jan 10, 2020 (healthday news) -- the us food and drug administration is adding to a list of recalled lots of popular heartburn medications -- including generic forms of zantac. What acid reflux medicine was recalled. Mylan pharmaceuticals has issued a recall of three lots of a medication used to treat acid reflux disease because trace amounts of a carcinogen were detected nizatidine capsules in 150 mg and.
what acid reflux medicine was recalled
These medications work to prevent heartburn and provide relief tied to acid ingestion by reducing the amount of acid the stomach makes the prescription version is used to treat and prevent ulcers of the stomach; it also treats gastroesophageal reflux disease (gerd) this recall was recently expanded to include the following products:. Mylan pharmaceuticals has issued a voluntary nationwide recall of three lots of nizatidine capsules due to a substance that could cause cancer. three lots of nizatidine capsules, usp, (including the 150mg and 300mg strengths), have been recalled due to detected trace amounts of an impurity of ndma (nitrosodimethylamine).. Dozens of additional products used to relieve heartburn, acid reflux recalled over probable cancer-causing impurity (source: pixabay) by kevin foster | november 23, 2019 at 5:52 pm est - updated.
